SNAI1: a key modulator of survival in lung squamous cell carcinoma and its association with metastasis
High SNAI1 expression is a robust prognostic indicator of poor survival in LUSC, independent of other clinical factors. Its association with immune checkpoint molecules highlights its potential as a therapeutic target. These findings underscore the prognostic and therapeutic relevance of SNAI1 in LUSC and possibly other cancers. Further research is warranted to explore targeted therapies against SNAI1.
Authors
- Rongkai Li
- Beibei Li
Institutions
- Xinxiang Central Hospital (CN)
- Henan Medical University (CN)
Publication Details
- Journal
- Journal of Cardiothoracic Surgery
- Published
- 2024-09-18
- DOI
- https://doi.org/10.1186/s13019-024-03044-8
- Citations
- 2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.84